<!DOCTYPE html><html lang="en-us" >

<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.2.0 for Hugo" />
  

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Yuri Pritykin" />

  
  
  
    
  
  <meta name="description" content="Adoptive T cell therapy (ACT) is a promising strategy for treating cancer, but it often fails because of cell intrinsic regulatory programs that limit the degree or duration of T cell function. In this study, we found that ectopic expression of microRNA-200c (miR-200c) markedly enhanced the antitumor activity of CD8&#43; cytotoxic T lymphocytes (CTLs) during ACT in multiple mouse models. CTLs transduced with miR-200c exhibited reduced apoptosis during engraftment and enhanced in vivo persistence, accompanied by up-regulation of the transcriptional regulator T cell factor 1 (TCF1) and the inflammatory cytokine tumor necrosis factor (TNF). miR-200c elicited these changes by suppressing the transcription factor Zeb1 and thereby inducing genes characteristic of epithelial cells. Overexpression of one of these genes, *Epcam*, was sufficient to augment therapeutic T cell responses against both solid and liquid tumors. These results identify the miR-200c–EpCAM axis as an avenue for improving ACT and demonstrate that select genetic perturbations can produce phenotypically distinct T cells with advantageous therapeutic properties." />

  
  <link rel="alternate" hreflang="en-us" href="https://pritykinlab.github.io/publication/2021-sci-transl-med-mir200/" />

  







  




  
  

  
  
  
    <meta name="theme-color" content="#3f51b5" />
  

  
  

  
  
  
  
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.9.0/css/academicons.min.css" integrity="sha512-W4yqoT1+8NLkinBLBZko+dFB2ZbHsYLDdr50VElllRcNt2Q4/GSs6u71UHKxB7S6JEMCp5Ve4xjh3eGQl/HRvg==" crossorigin="anonymous">
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css" integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin="anonymous">

    
    

    
    
    
      
    
    

    
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.css" integrity="sha512-1xoFisiGdy9nvho8EgXuXvnpR5GAMSjFwp40gSRE3NwdUdIMIKuPa7bqoUhLD0O/5tPNhteAsE5XyyMi5reQVA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.f39d388d66890b85c6a2848a42ecf9e1.css" />

  




<script async src="https://www.googletagmanager.com/gtag/js?id=UA-138603211-2"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'UA-138603211-2', {});
  gtag('set', {'cookie_flags': 'SameSite=None;Secure'});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  

  

  




  
  
  

  

  
    <link rel="manifest" href="/index.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hu319984673dac842ac8ba1aa7906c04f1_1673_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu319984673dac842ac8ba1aa7906c04f1_1673_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://pritykinlab.github.io/publication/2021-sci-transl-med-mir200/" />

  
  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary" />
  
  <meta property="og:site_name" content="Pritykin Lab" />
  <meta property="og:url" content="https://pritykinlab.github.io/publication/2021-sci-transl-med-mir200/" />
  <meta property="og:title" content="Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy | Pritykin Lab" />
  <meta property="og:description" content="Adoptive T cell therapy (ACT) is a promising strategy for treating cancer, but it often fails because of cell intrinsic regulatory programs that limit the degree or duration of T cell function. In this study, we found that ectopic expression of microRNA-200c (miR-200c) markedly enhanced the antitumor activity of CD8&#43; cytotoxic T lymphocytes (CTLs) during ACT in multiple mouse models. CTLs transduced with miR-200c exhibited reduced apoptosis during engraftment and enhanced in vivo persistence, accompanied by up-regulation of the transcriptional regulator T cell factor 1 (TCF1) and the inflammatory cytokine tumor necrosis factor (TNF). miR-200c elicited these changes by suppressing the transcription factor Zeb1 and thereby inducing genes characteristic of epithelial cells. Overexpression of one of these genes, *Epcam*, was sufficient to augment therapeutic T cell responses against both solid and liquid tumors. These results identify the miR-200c–EpCAM axis as an avenue for improving ACT and demonstrate that select genetic perturbations can produce phenotypically distinct T cells with advantageous therapeutic properties." /><meta property="og:image" content="https://pritykinlab.github.io/media/icon_hu319984673dac842ac8ba1aa7906c04f1_1673_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://pritykinlab.github.io/media/icon_hu319984673dac842ac8ba1aa7906c04f1_1673_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2021-09-15T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2021-09-15T00:00:00&#43;00:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://pritykinlab.github.io/publication/2021-sci-transl-med-mir200/"
  },
  "headline": "Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy",
  
  "datePublished": "2021-09-15T00:00:00Z",
  "dateModified": "2021-09-15T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Minggang Zhang"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Pritykin Lab",
    "logo": {
      "@type": "ImageObject",
      "url": "https://pritykinlab.github.io/media/icon_hu319984673dac842ac8ba1aa7906c04f1_1673_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Adoptive T cell therapy (ACT) is a promising strategy for treating cancer, but it often fails because of cell intrinsic regulatory programs that limit the degree or duration of T cell function. In this study, we found that ectopic expression of microRNA-200c (miR-200c) markedly enhanced the antitumor activity of CD8+ cytotoxic T lymphocytes (CTLs) during ACT in multiple mouse models. CTLs transduced with miR-200c exhibited reduced apoptosis during engraftment and enhanced in vivo persistence, accompanied by up-regulation of the transcriptional regulator T cell factor 1 (TCF1) and the inflammatory cytokine tumor necrosis factor (TNF). miR-200c elicited these changes by suppressing the transcription factor Zeb1 and thereby inducing genes characteristic of epithelial cells. Overexpression of one of these genes, *Epcam*, was sufficient to augment therapeutic T cell responses against both solid and liquid tumors. These results identify the miR-200c–EpCAM axis as an avenue for improving ACT and demonstrate that select genetic perturbations can produce phenotypically distinct T cells with advantageous therapeutic properties."
}
</script>

  

  

  

  





  <title>Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy | Pritykin Lab</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="e950e1ee685407e6c1207e99763cdcff" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.c2ae95842e5b33a787c7b8c567e989a4.js"></script>

  




  <div class="page-header">
    












<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container-xl">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/">Pritykin Lab</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/">Pritykin Lab</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#research"><span>Research</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#news"><span>News</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#people"><span>People</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#featured"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#teaching"><span>Teaching</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#jobs"><span>Join us</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
            
            
            
              
            
            
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

      
      
        
      

      
      

      
      

      
      

    </ul>

  </div>
</nav>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/minggang-zhang/">Minggang Zhang</a></span>, <span >
      <a href="/author/zeguo-zhao/">Zeguo Zhao</a></span>, <span >
      <a href="/author/yuri-pritykin/">Yuri Pritykin</a></span>, <span >
      <a href="/author/margaret-hannum/">Margaret Hannum</a></span>, <span >
      <a href="/author/andrew-c.-scott/">Andrew C. Scott</a></span>, <span >
      <a href="/author/fengshen-kuo/">Fengshen Kuo</a></span>, <span >
      <a href="/author/viraj-sanghvi/">Viraj Sanghvi</a></span>, <span >
      <a href="/author/timothy-a.-chan/">Timothy A. Chan</a></span>, <span >
      <a href="/author/venkatraman-seshan/">Venkatraman Seshan</a></span>, <span >
      <a href="/author/hans-guido-wendel/">Hans-Guido Wendel</a></span>, <span >
      <a href="/author/andrea-schietinger/">Andrea Schietinger</a></span>, <span >
      <a href="/author/michel-sadelain/">Michel Sadelain</a></span>, <span >
      <a href="/author/morgan-huse/">Morgan Huse</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    September 2021
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    




<div class="btn-links mb-3">
  
  








  
    
  



<a class="btn btn-outline-primary btn-page-header" href="/files/2021-sci-transl-med-cd8t.pdf" target="_blank" rel="noopener">
  PDF
</a>















<a class="btn btn-outline-primary btn-page-header" href="https://doi.org/doi:10.1126/scitranslmed.abg4328" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Adoptive T cell therapy (ACT) is a promising strategy for treating cancer, but it often fails because of cell intrinsic regulatory programs that limit the degree or duration of T cell function. In this study, we found that ectopic expression of microRNA-200c (miR-200c) markedly enhanced the antitumor activity of CD8+ cytotoxic T lymphocytes (CTLs) during ACT in multiple mouse models. CTLs transduced with miR-200c exhibited reduced apoptosis during engraftment and enhanced in vivo persistence, accompanied by up-regulation of the transcriptional regulator T cell factor 1 (TCF1) and the inflammatory cytokine tumor necrosis factor (TNF). miR-200c elicited these changes by suppressing the transcription factor Zeb1 and thereby inducing genes characteristic of epithelial cells. Overexpression of one of these genes, <em>Epcam</em>, was sufficient to augment therapeutic T cell responses against both solid and liquid tumors. These results identify the miR-200c–EpCAM axis as an avenue for improving ACT and demonstrate that select genetic perturbations can produce phenotypically distinct T cells with advantageous therapeutic properties.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>Science Translational Medicine</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    
















  
  
    




  
    




  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/yuri-pritykin/"><img class="avatar mr-3 avatar-circle" src="/author/yuri-pritykin/avatar_huec0bfe217818550ceabba5e59bf9fbff_901831_270x270_fill_q75_lanczos_center.jpg" alt="Yuri Pritykin"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/yuri-pritykin/">Yuri Pritykin</a></h5>
      <h6 class="card-subtitle">Assistant Professor of Computer Science and Genomics</h6>
      
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:pritykin@princeton.edu" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://scholar.google.com/citations?hl=en&amp;user=Arx56RkJBrYC&amp;view_op=list_works&amp;sortby=pubdate" target="_blank" rel="noopener">
        <i class="ai ai-google-scholar"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://twitter.com/YuriPritykin" target="_blank" rel="noopener">
        <i class="fab fa-twitter"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://www.linkedin.com/in/yuri-pritykin-5b290993" target="_blank" rel="noopener">
        <i class="fab fa-linkedin"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://orcid.org/0000-0001-6589-981X" target="_blank" rel="noopener">
        <i class="ai ai-orcid"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  














  
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  

  

  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-modules" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js" integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin="anonymous"></script>

      
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      

      
      

      

      

    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.js" integrity="sha512-SeiQaaDh73yrb56sTW/RgVdi/mMqNeM2oBwubFHagc5BkixSpP1fvqF47mKzPGWYSSy4RwbBunrJBQ4Co8fRWA==" crossorigin="anonymous"></script>
    

    
    

    
    
    

    
    

    
    
    
    

    
    <script src="/js/bootstrap.bundle.min.6aed84840afc03ab4d5750157f69c120.js"></script>

    
    

    
    
    
    
    
    
    
    
    
    <script src="/en/js/wowchemy.min.0d73d39836744f4433ae9aed115721e7.js"></script>

    






</body>
</html>
